Max Grogl is a dedicated and accomplished research and development manager with more than 35 years of diverse experience in biomedical research and development at every level from investigator to senior management during service as a commissioned officer in the US Army Medical Service Corps. His experience includes human and animal use review, clinical trials, partnership negotiations, management and oversight of drugs, vaccines, devices and medical information product development, developing research and cooperative agreements, and planning at the project, program and strategic levels.

He can act as effective interface with scientists and senior leaders in both government and private sector biomedical research, as well as the most senior leadership within the Departments of Army, Navy, Defense, State, Health Human Services and US Congress. He is fluent in multiple languages with effective interface with international organizations and governments. He is a world expert in leishmaniasis, tropical medicine, drug development, manufacturing and Good manufacturing practices (GMP), GCP, ethical conduct and regulations of clinical trials and biosafety and biosurety issues. He has over 150 scientific publications and 12 patents.

He brings over three decades of global leadership in the life sciences and animal health sectors, with deep expertise in strategic marketing, innovation, organizational development, and international business expansion. As President of THIEGO, he advises life science companies on growth strategies, particularly in Latin America and Asia, acting as both mentor and executive coach. His prior executive roles at Virbac, including Area Director for Latin America and Asia, have equipped him with unparalleled experience in market development, M&A, and cross-cultural leadership. Thierry’s strategic insight and global network are invaluable assets to our Advisory Board as we expand our international footprint and long-term impact.

She is a seasoned, dynamic and creative scientist-entrepreneur with almost 20 years’ experience in innovative veterinary drug and vaccine discovery and development. She has booked successes as a co-founder and chief development officer of a top-20 innovator biotech company in the animal health space, and as general manager of a successful biotech company. She held and holds positions as vice-president discovery research and chief scientist in multiple early and later stage animal health research companies.

Pharmaceutical Development

He is a highly experienced entrepreneurial product developer with over 25 years of expertise in pharmaceutical drug innovation, with a particular focus on novel treatments for infectious diseases to address global health challenges. Throughout his career, he has played a critical role in translating lead compounds into cost-effective, market-ready pharmaceutical products. Platteeuw is the inventor of over 30 patents across leading companies.

Leishmania Clinical Expert

Over the last 16 years Dr Berman has been working as the Vice President for Clinical and Regulatory Affairs at Fast-Track Drugs & Biologics, LLC. Prior to that, Dr Berman had over 20 years experience in clinical and regulatory affairs at large government institutions – Walter Reed Army Institute of Research and the NIH. His main focus has been on the neglected tropical infectious diseases malaria and leishmaniasis. Dr Berman has been the author and/or co-author of over 160 publications. For over 20 years he was a member or chair of WHO Tropical Disease Research committees. Dr Berman was IND director for over a dozen pharmaceuticals and was clinical lead for two submissions/approvals at FDA that obtained a Tropical Disease Priority Review Voucher.